Early ensitrelvir treatment could offer additional benefits for household contacts exposed to SARS-CoV-2, including reducing viral replication and symptom severity …
Daily oral antiretroviral therapy (ART) represents the current standard of care (SOC) for people with HIV (PWH). Once-weekly oral treatment …
The entry of prediction markets into the pharmaceutical sector means new pathways to access money, but also brings new risks. Prediction …
Vertex Pharmaceuticals and CRISPR Therapeutics have secured a label expansion for their gene editing therapy Casgevy (exagamglogene autotemcel) from UK …
Eli Lilly posted another strong quarter fuelled by its obesity franchise medications, with company revenue soaring 39% compared to Q3 …
Glenmark Pharmaceuticals has inaugurated an approximately 160,000ft² distribution hub in Allentown, Pennsylvania, US, consolidating all of its American shipping operations into …
Dren Bio has secured $350m in an oversubscribed private financing round to advance its primary investigational therapy, dibotatug (DR-01), via …
US health secretary Robert F Kennedy Jr (RFK Jr) has debuted a policy that allows specific licensed professionals to use …
One of the standout M&A deals in 2025 was concluded as that year drew to a close. December 2025 saw …
At the IDWeek 2026 conference in Washington, DC, Dr Brigid Wilson from the VA Northeast Ohio Healthcare System and Case Western Reserve …
The UK Autumn Budget offered little in the way of new measures specifically for the life sciences sector, though incentives …
This year's European Society of Medical Oncology (ESMO) Congress has come to a close, with hundreds of studies having been …
Enthorin Therapeutics has signed an option-to-license agreement with Rumi Therapeutics to advance ENT-7340 for Fragile X syndrome (FXS), as well …
US-based AI-focused pharmaceutical company Formation Bio has launched the Formation Bio Drug Development Accelerator Fund with a capital of $600m …
Swiss pharma company Ferring Pharmaceuticals has agreed to acquire startup Gameto for up to $1.38bn as the company looks to …
